Intermittent fasting could help tackle diabetes – here's the science

August 21, 2017 by Nick Lesica, The Conversation
Credit: iordani/shutterstock

Intermittent fasting is currently all the rage. But don't be fooled: it's much more than just the latest fad. Recent studies of this kind of fasting – with restricted eating part of the time, but not all of the time – have produced a number of successes, but the latest involving diabetes might be the most impressive yet.

The idea of intermittent fasting arose after scientists were wowed by the effects of constant calorie restriction. A number of studies in many different animals have shown that restricted eating throughout adulthood leads to dramatic improvements in lifespan and general health.

The reasons for these improvements aren't yet clear. Part of it seems to be that going without food gives cells in the body a much needed break to perform maintenance and repair. But the lack of food also forces cells to resort to alternative sources of energy. Some of these, such as ketones – molecules created in the liver from recycled fat – appear to be beneficial.

'Fasting' without fasting

The problem is that constant calorie restriction isn't practical: it's easy for scientists to impose upon , but hard for humans to impose upon themselves in the real world. Fortunately, we've learned that constant calorie restriction isn't really necessary. Intermittent fasting seems to have many of the same benefits.

There are two main types of intermittent fasting. One type, known as "time restricted feeding", requires eating only during a few hours of the day – say between 10am and 6pm. This approach gives the body a long break from food each night, and also reinforces beneficial circadian rhythms.

The other type of intermittent fasting – made popular by the 5:2 diet – is known as "periodic fasting". This approach involves alternating between long periods of unrestricted eating and short periods of eating very little (five days of eating normally, two days of eating restricted calories).

It isn't yet clear whether one type of intermittent fasting is better than the other. But the data so far suggest that both types can work.

Tackling diabetes in mice and men

The recent studies of the effects of intermittent fasting on diabetes have focused on periodic fasting in particular. As a first step, researchers led by Valter Longo at the University of Southern California, began by testing whether periodic fasting could cure diabetes in mice. They used mutant mice that lack the fat hormone leptin to regulate their food intake. These mice constantly overeat and become obese and diabetic in early adulthood.

The researchers found that after just a few months of periodic fasting – alternating seven unrestricted eating days with four restricted days – the diabetes was cured. This is an amazing result. But what's even more amazing is the reason behind it.

The mice lost weight during the periodic fasting, which helped of course. But that wasn't the whole story. Periodic fasting actually solved the problem directly at one of its sources: the pancreas.

Diabetes is a disease characterised by excess blood "sugar", which really means excess blood glucose. It's largely an insulin problem. Normally, insulin causes cells in the body to take in glucose from the blood. But with , glucose stays in the blood because cells no longer take it in. This is partly because many cells lose their sensitivity to insulin, but also because the pancreas stops making it.

It turns out that the periodic fasting made the pancreas start producing insulin again. The days of restricted eating gave the pancreas a break that allowed it to remove and recycle many of its cells. Then, when the mice started eating again, new that were capable of producing insulin emerged.

So the pancreas actually shrunk during the four restricted eating days, and regrew during the seven unrestricted eating days. After several such cycles of shrinking, recycling, and regrowing, the pancreas was nearly as good as new.

The big question, of course, it whether intermittent fasting will have the same effects in humans. The answer is not yet clear, but the initial indications from a recently published phase two clinical trial, again led by Longo, are promising.

In this study, 100 people went through a series of 30-day cycles of periodic fasting, each with 25 days of unrestricted eating and five days of restricted eating. After only three cycles, those subjects who started the trial with high saw big improvements. And, importantly, none of the subjects in the trial experienced any harmful effects.

So the evidence in support of intermittent fasting keeps growing. Does that mean that we should all be doing it? Not necessarily.

Intermittent fasting seems to be most beneficial for those who are already overweight and unhealthy. While it does also seem to have some benefits for lean and healthy lab animals, it's not yet clear whether the same is true for humans.

A much larger phase three trial of intermittent fasting in humans that will clarify a lot of things is set to begin soon. The results will no doubt be very exciting.

Explore further: Fasting-mimicking diet may reverse diabetes

Related Stories

Fasting-mimicking diet may reverse diabetes

February 23, 2017
A diet designed to imitate the effects of fasting appears to reverse diabetes by reprogramming cells, a new USC-led study shows.

What are 'fasting' diets and do they help you lose weight?

May 8, 2017
Trying to lose weight is hard work. You need to plan meals and snacks, and make a big effort to avoid situations that trigger more eating and drinking than you'd planned. Dieting can also be very antisocial. But what if you ...

Blood sugars may be key to optimizing weight loss approaches

August 11, 2017
What if a simple blood test could help you determine the best strategy for weight loss, before you even started? Additional analysis of a study conducted by researchers at the Jean Mayer USDA Human Nutrition Research Center ...

Forthcoming study explores use of intermittent fasting in diabetes as cardiovascular disease

April 26, 2013
Intermittent fasting is all the rage, but scientific evidence showing how such regimes affect human health is not always clear cut. Now a scientific review in the British Journal of Diabetes and Vascular Disease suggests ...

Is alternate-day fasting more effective for weight loss?

May 1, 2017
Alternate day fasting regimens have increased in popularity because some patients find it difficult to adhere to a conventional weight-loss diet.

Research suggests intermittent fasting provides health benefits

November 18, 2014
(Medical Xpress)—Intermittently restricting food intake could help prevent obesity and associated diseases prevalent in modern society, according to an analysis by Mark P. Mattson of the National Institute on Aging in Baltimore ...

Recommended for you

Diabetes pill might replace injection to control blood sugar

October 17, 2017
(HealthDay)— An injectable class of diabetes medication—called glucagon-like peptide-1 or GLP-1—might one day be available in pill form, research suggests.

Skimping on sleep may contribute to gestational diabetes

October 17, 2017
The amount of time spent sleeping in the United States has dropped significantly in the past twenty years with almost a quarter of women and 16 percent of men experiencing insufficient sleep. Now, a new study has found that ...

Artificial pancreas performs well in clinical trial

October 16, 2017
During more than 60,000 hours of combined use of a novel artificial pancreas system, participants in a 12-week, multi-site clinical trial showed significant improvements in two key measures of well-being in people living ...

Omega-6 fats may help prevent type 2 diabetes

October 11, 2017
The risk of developing type 2 diabetes could be significantly reduced by eating a diet rich in omega-6 polyunsaturated fats, a new study suggests.

Where there's type 1 diabetes, celiac disease may follow

October 10, 2017
(HealthDay)—Parents of young children with type 1 diabetes need to be on the lookout for symptoms of another autoimmune condition—celiac disease, new research suggests.

Type 1 diabetes and the microbiota—MAIT cells as biomarkers and new therapeutic targets

October 10, 2017
Together with colleagues from AP-HP Necker–Enfants Malades Hospital in Paris, scientists from the Cochin Institute (CNRS / INSERM / Paris Descartes University) have discovered that the onset of type 1 diabetes is preceded ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.